GLP-1 receptor agonists are generally discontinued before planned conception according to labeling, and phentermine-topiramate has specific fetal toxicity risk because of topiramate-associated oral clefts
Orforglipron, a once-daily oral GLP-1 pill, led to an average weight loss of 11.2% over 72 weeks, along with improvements in blood pressure, triglycerides, and cholesterol
Patients receive detailed injection training materials and can contact their care team with questions about side effects, technique, or protocol adjustments
When you're operating at the edge of your body's recovery capacity, even marginal improvements in cellular efficiency can produce measurable performance gains
Potential Immunomodulatory Effects and Research Findings The theoretical basis for investigating Ozempic in autoimmune disease stems from several mechanistic pathways identified in laboratory and animal studies
and competitive developments